Extension for Community Healthcare Outcomes Autism Replication Evaluation
NCT ID: NCT03677089
Last Updated: 2020-04-30
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
148 participants
INTERVENTIONAL
2016-09-01
2018-11-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Extension for Community Healthcare Outcomes (ECHO) Autism Diagnostic Study in Primary Care Setting
NCT05223374
Treatment Monitoring in Autism Spectrum Disorder (ASD) in Children
NCT05675371
Can Novel Telemedicine Tools Reduce Disparities Related to Early Identification of Autism
NCT03847337
Improving the Part C Early Intervention Service Delivery System for Children with ASD
NCT05114538
Can a Novel Telemedicine Tool Reduce Disparities Related to the Identification of Preschool Children With Autism?
NCT05373173
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Outcomes are measured at baseline (Month 0), during the intervention (approximately 3 months after the start of the intervention) and after the end of the intervention (approximately 6 months after the start of the intervention). An additional measurement was made 3 months after the end of the intervention to assess whether deterioration occurs after clinic participation ends.
All participants received the intervention.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
All participants received the intervention.
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ECHO Cohort
Sites undergo 12 ECHO Autism telehealth clinics. Clusters of two sites each will initiate intervention with 3 months between the start of each cluster.
12 ECHO Autism telehealth clinics
Twice-monthly 2-hour ECHO Autism Clinics will be provided during a 6-month period. Each Clinic will include a didactic presentation, 2 to 3 Primary Care Provider-generated case presentations, expert feedback, and group discussion. Although the ECHO Clinic will include discussion of specific cases, no identifiable personal health information will be shared, individual patients will not be identified, and no direct patient care will be provided.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
12 ECHO Autism telehealth clinics
Twice-monthly 2-hour ECHO Autism Clinics will be provided during a 6-month period. Each Clinic will include a didactic presentation, 2 to 3 Primary Care Provider-generated case presentations, expert feedback, and group discussion. Although the ECHO Clinic will include discussion of specific cases, no identifiable personal health information will be shared, individual patients will not be identified, and no direct patient care will be provided.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Currently providing care for children
* Professional training in: general pediatrics, family medicine, advance practice nursing (i.e. nurse practitioner or physician assistant)
* Active medical license in the state of practice
* Patient population is at least 50% underserved
Exclusion Criteria
* Subspecialist (e.g., psychiatrists, neurologists, developmental and behavioral pediatricians)
* Practicing within the same practice as another PCP participant (i.e., only one PCP participant from any given practice may be enrolled as a research participant in the study)
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Toronto
OTHER
Children's Hospital of Philadelphia
OTHER
University of Pittsburgh
OTHER
University of Rochester
OTHER
Children's Hospital Medical Center, Cincinnati
OTHER
University of Arkansas
OTHER
Nationwide Children's Hospital
OTHER
Vanderbilt University Medical Center
OTHER
University of California, Irvine
OTHER
University of Missouri-Columbia
OTHER
Massachusetts General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Karen Kuhlthau
Associate Professor of Pediatrics
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kristin Sohl, MD, FAAP
Role: PRINCIPAL_INVESTIGATOR
University of Missouri Health Care, Thompson Center for Autism
Micah Mazurek, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Virginia, Curry School of Education
References
Explore related publications, articles, or registry entries linked to this study.
Mazurek MO, Parker RA, Chan J, Kuhlthau K, Sohl K; ECHO Autism Collaborative. Effectiveness of the Extension for Community Health Outcomes Model as Applied to Primary Care for Autism: A Partial Stepped-Wedge Randomized Clinical Trial. JAMA Pediatr. 2020 May 1;174(5):e196306. doi: 10.1001/jamapediatrics.2019.6306. Epub 2020 May 4.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan: Original
Document Type: Statistical Analysis Plan: Amendment 1
Document Type: Statistical Analysis Plan: Amendment 2
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UA3MC11054
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
2016P000415
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.